Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
The expression of NF-B, iNOS, and VEGF proteins was significantly reduced in the group treated with soybean compared to that in the disease group
This pilot clinical study suggests that GSH may improve liver health in patients with NAFLD by reducing ALT, triglycerides, fatty acids, and liver fat
Given the burden of CVD, identifying more effective intervention targets, especially sustainable dietary interventions applicable in daily life, is helpful for primary prevention and primary care
1 CagriSema is a fixed-dose combination of a long-acting amylin analogue, cagrilintide 2.4 mg, and the GLP-1 receptor agonist, semaglutide 2.4 mg
US$ 26.23
US$ 23.20
US$ 26.87
US$ 29.59
US$ 20.96
US$ 21.33
US$ 23.55
US$ 27.60
US$ 29.69
US$ 21.18
